Working… Menu

Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04246489
Recruitment Status : Active, not recruiting
First Posted : January 29, 2020
Last Update Posted : February 16, 2021
Merck KGaA, Darmstadt, Germany
Information provided by (Responsible Party):
EMD Serono ( EMD Serono Research & Development Institute, Inc. )